RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Suzhou Highfine Biotech Co Stock

Suzhou Highfine Biotech Co P/S 2024

Suzhou Highfine Biotech Co P/S

8.49

Ticker

301393.SZ

ISIN

CNE1000064T6

As of Nov 20, 2024, Suzhou Highfine Biotech Co's P/S ratio stood at 8.49, a 0% change from the 0 P/S ratio recorded in the previous year.

The Suzhou Highfine Biotech Co P/S history

Suzhou Highfine Biotech Co Aktienanalyse

What does Suzhou Highfine Biotech Co do?

Suzhou Highfine Biotech Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Suzhou Highfine Biotech Co's P/S Ratio

Suzhou Highfine Biotech Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Suzhou Highfine Biotech Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Suzhou Highfine Biotech Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Suzhou Highfine Biotech Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Suzhou Highfine Biotech Co stock

What is the price-to-earnings ratio of Suzhou Highfine Biotech Co?

The price-earnings ratio of Suzhou Highfine Biotech Co is currently 8.49.

How has the price-earnings ratio of Suzhou Highfine Biotech Co changed compared to last year?

The price-to-earnings ratio of Suzhou Highfine Biotech Co has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Suzhou Highfine Biotech Co high compared to other companies?

Yes, the price-to-earnings ratio of Suzhou Highfine Biotech Co is high compared to other companies.

How does an increase in the price-earnings ratio of Suzhou Highfine Biotech Co affect the company?

An increase in the price-earnings ratio of Suzhou Highfine Biotech Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Suzhou Highfine Biotech Co affect the company?

A decrease in the price-earnings ratio of Suzhou Highfine Biotech Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Suzhou Highfine Biotech Co?

Some factors that influence the price-earnings ratio of Suzhou Highfine Biotech Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Suzhou Highfine Biotech Co pay?

Over the past 12 months, Suzhou Highfine Biotech Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 0.57 %. For the coming 12 months, Suzhou Highfine Biotech Co is expected to pay a dividend of 0.25 CNY.

What is the dividend yield of Suzhou Highfine Biotech Co?

The current dividend yield of Suzhou Highfine Biotech Co is 0.57 %.

When does Suzhou Highfine Biotech Co pay dividends?

Suzhou Highfine Biotech Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Suzhou Highfine Biotech Co?

Suzhou Highfine Biotech Co paid dividends every year for the past 0 years.

What is the dividend of Suzhou Highfine Biotech Co?

For the upcoming 12 months, dividends amounting to 0.25 CNY are expected. This corresponds to a dividend yield of 0.57 %.

In which sector is Suzhou Highfine Biotech Co located?

Suzhou Highfine Biotech Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Suzhou Highfine Biotech Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Suzhou Highfine Biotech Co from 5/23/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 5/23/2024.

When did Suzhou Highfine Biotech Co pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of Suzhou Highfine Biotech Co in the year 2023?

In the year 2023, Suzhou Highfine Biotech Co distributed 0 CNY as dividends.

In which currency does Suzhou Highfine Biotech Co pay out the dividend?

The dividends of Suzhou Highfine Biotech Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Suzhou Highfine Biotech Co

Our stock analysis for Suzhou Highfine Biotech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suzhou Highfine Biotech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.